SCHEMBL4699137

SCHEMBL4699137

O=C(O)CCCCCNc1ncnc2oc(-c3ccccc3)c(Br)c12

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHEK1 O14757 2/20 0.55
EGFR P00533 3/20 0.54
AURKA O14965 12/20 0.54
MAP2K1 Q02750 1/20 0.54
KMT2A Q03164 2/20 0.52
RAD52 P43351 1/20 0.52
RXFP1 Q9HBX9 1/20 0.49
MEN1 O00255 1/20 0.48
AURKB Q96GD4 1/20 0.48
KDM4E B2RXH2 2/20 0.48
USP2 O75604 2/20 0.48
ALDH1A1 P00352 2/20 0.48
MAPT P10636 2/20 0.48
HPGD P15428 2/20 0.48
TSHR P16473 2/20 0.48
MAPK1 P28482 2/20 0.48
HSD17B10 Q99714 2/20 0.48
LMNA P02545 1/20 0.47
TP53 P04637 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2179113 0.90 AURKA (0.56) CHEK1EGFRAURKAMAP2K1KMT2A
SCHEMBL4525559 0.88 CHEK1 (0.72) CHEK1EGFRAURKAMAP2K1KMT2A
SCHEMBL6750461 0.83 AURKA (0.65) CHEK1EGFRAURKAMAP2K1KMT2A
SCHEMBL6750083 0.83 CHEK1 (0.64) CHEK1EGFRAURKAMAP2K1KMT2A
SCHEMBL6750519 0.83 AURKA (0.67) CHEK1EGFRAURKAMAP2K1KMT2A
SCHEMBL4527832 0.83 AURKA (0.66) CHEK1EGFRAURKAMAP2K1KMT2A
SCHEMBL6750413 0.81 AURKA (0.64) CHEK1EGFRAURKAMAP2K1KMT2A
SCHEMBL6750552 0.81 AURKA (0.62) CHEK1EGFRAURKAMAP2K1KMT2A
SCHEMBL4531234 0.81 KMT2A (0.71) CHEK1EGFRAURKAMAP2K1KMT2A
SCHEMBL6750148 0.81 CHEK1 (0.61) CHEK1EGFRAURKAMAP2K1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008131858-A2 USE OF ACYCLICALLY SUBSTITUTED FUROPYRIMIDINE DERIVATIVES FOR TREATING PULMONARY ARTERIAL HYPERTONIA BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2008-11-06 WO disclosed
EP-1966217-A1 NOVEL, ACYCLIC SUBSTITUTED FUROPYRIMIDINE DERIVATIVES AND USE THEREOF FOR TREATING CARDIOVASCULAR DISEASES Bayer HealthCare AG (DE) 2008-09-10 EP disclosed
WO-2007079862-A1 NOVEL, ACYCLIC SUBSTITUTED FUROPYRIMIDINE DERIVATIVES AND USE THEREOF FOR TREATING CARDIOVASCULAR DISEASES BAYER HEALTHCARE AG (DE) 2007-07-19 WO disclosed